184 related articles for article (PubMed ID: 27233294)
1. Prediction of Altered Bile Acid Disposition Due to Inhibition of Multiple Transporters: An Integrated Approach Using Sandwich-Cultured Hepatocytes, Mechanistic Modeling, and Simulation.
Guo C; Yang K; Brouwer KR; St Claire RL; Brouwer KL
J Pharmacol Exp Ther; 2016 Aug; 358(2):324-33. PubMed ID: 27233294
[TBL] [Abstract][Full Text] [Related]
2. Prediction of Hepatic Efflux Transporter-Mediated Drug Interactions: When Is it Optimal to Measure Intracellular Unbound Fraction of Inhibitors?
Guo C; Yang K; Liao M; Xia CQ; Brouwer KR; Brouwer KLR
J Pharm Sci; 2017 Sep; 106(9):2401-2406. PubMed ID: 28465154
[TBL] [Abstract][Full Text] [Related]
3. Species differences in hepatobiliary disposition of taurocholic acid in human and rat sandwich-cultured hepatocytes: implications for drug-induced liver injury.
Yang K; Pfeifer ND; Köck K; Brouwer KL
J Pharmacol Exp Ther; 2015 May; 353(2):415-23. PubMed ID: 25711339
[TBL] [Abstract][Full Text] [Related]
4. An in vitro assay to assess transporter-based cholestatic hepatotoxicity using sandwich-cultured rat hepatocytes.
Ansede JH; Smith WR; Perry CH; St Claire RL; Brouwer KR
Drug Metab Dispos; 2010 Feb; 38(2):276-80. PubMed ID: 19910518
[TBL] [Abstract][Full Text] [Related]
5. Modeling approach for multiple transporters-mediated drug-drug interactions in sandwich-cultured human hepatocytes: effect of cyclosporin A on hepatic disposition of mycophenolic acid phenyl-glucuronide.
Matsunaga N; Suzuki K; Nakanishi T; Ogawa M; Imawaka H; Tamai I
Drug Metab Pharmacokinet; 2015 Apr; 30(2):142-8. PubMed ID: 25989889
[TBL] [Abstract][Full Text] [Related]
6. Farnesoid X Receptor Agonists Obeticholic Acid and Chenodeoxycholic Acid Increase Bile Acid Efflux in Sandwich-Cultured Human Hepatocytes: Functional Evidence and Mechanisms.
Guo C; LaCerte C; Edwards JE; Brouwer KR; Brouwer KLR
J Pharmacol Exp Ther; 2018 May; 365(2):413-421. PubMed ID: 29487110
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic Modeling of the Hepatic Disposition of Estradiol-17
Ito K; Sjöstedt N; Brouwer KLR
Drug Metab Dispos; 2020 Feb; 48(2):116-122. PubMed ID: 31744810
[TBL] [Abstract][Full Text] [Related]
8. Use of cryopreserved human hepatocytes in sandwich culture to measure hepatobiliary transport.
Bi YA; Kazolias D; Duignan DB
Drug Metab Dispos; 2006 Sep; 34(9):1658-65. PubMed ID: 16782767
[TBL] [Abstract][Full Text] [Related]
9. Use of primary rat hepatocytes in the gel entrapment culture to predict in vivo biliary excretion.
Yin J; Meng Q
Xenobiotica; 2012 May; 42(5):417-28. PubMed ID: 22106963
[TBL] [Abstract][Full Text] [Related]
10. Differential disposition of chenodeoxycholic acid versus taurocholic acid in response to acute troglitazone exposure in rat hepatocytes.
Marion TL; Perry CH; St Claire RL; Yue W; Brouwer KL
Toxicol Sci; 2011 Apr; 120(2):371-80. PubMed ID: 21262925
[TBL] [Abstract][Full Text] [Related]
11. Alpha-naphthylisothiocyanate modulates hepatobiliary transporters in sandwich-cultured rat hepatocytes.
Guo C; He L; Yao D; A J; Cao B; Ren J; Wang G; Pan G
Toxicol Lett; 2014 Jan; 224(1):93-100. PubMed ID: 24120425
[TBL] [Abstract][Full Text] [Related]
12. Understanding the Interplay Between Uptake and Efflux Transporters Within In Vitro Systems in Defining Hepatocellular Drug Concentrations.
Cantrill C; Houston JB
J Pharm Sci; 2017 Sep; 106(9):2815-2825. PubMed ID: 28478131
[TBL] [Abstract][Full Text] [Related]
13. Uremic solutes modulate hepatic bile acid handling and induce mitochondrial toxicity.
Weigand KM; Schirris TJJ; Houweling M; van den Heuvel JJMW; Koenderink JB; Dankers ACA; Russel FGM; Greupink R
Toxicol In Vitro; 2019 Apr; 56():52-61. PubMed ID: 30639138
[TBL] [Abstract][Full Text] [Related]
14. Differential inhibition of rat and human Na+-dependent taurocholate cotransporting polypeptide (NTCP/SLC10A1)by bosentan: a mechanism for species differences in hepatotoxicity.
Leslie EM; Watkins PB; Kim RB; Brouwer KL
J Pharmacol Exp Ther; 2007 Jun; 321(3):1170-8. PubMed ID: 17374746
[TBL] [Abstract][Full Text] [Related]
15. Fasiglifam (TAK-875) Inhibits Hepatobiliary Transporters: A Possible Factor Contributing to Fasiglifam-Induced Liver Injury.
Li X; Zhong K; Guo Z; Zhong D; Chen X
Drug Metab Dispos; 2015 Nov; 43(11):1751-9. PubMed ID: 26276582
[TBL] [Abstract][Full Text] [Related]
16. Hepatobiliary disposition of 17-OHPC and taurocholate in fetal human hepatocytes: a comparison with adult human hepatocytes.
Sharma S; Ellis EC; Gramignoli R; Dorko K; Tahan V; Hansel M; Mattison DR; Caritis SN; Hines RN; Venkataramanan R; Strom SC
Drug Metab Dispos; 2013 Feb; 41(2):296-304. PubMed ID: 23129211
[TBL] [Abstract][Full Text] [Related]
17. Improved extrapolation of hepatobiliary clearance from in vitro sandwich cultured rat hepatocytes through absolute quantification of hepatobiliary transporters.
Li N; Singh P; Mandrell KM; Lai Y
Mol Pharm; 2010 Jun; 7(3):630-41. PubMed ID: 20438085
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes.
Hartman JC; Brouwer K; Mandagere A; Melvin L; Gorczynski R
Can J Physiol Pharmacol; 2010 Jun; 88(6):682-91. PubMed ID: 20628435
[TBL] [Abstract][Full Text] [Related]
19. Culture period-dependent changes in the uptake of transporter substrates in sandwich-cultured rat and human hepatocytes.
Kotani N; Maeda K; Watanabe T; Hiramatsu M; Gong LK; Bi YA; Takezawa T; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2011 Sep; 39(9):1503-10. PubMed ID: 21673128
[TBL] [Abstract][Full Text] [Related]
20. Ritonavir, saquinavir, and efavirenz, but not nevirapine, inhibit bile acid transport in human and rat hepatocytes.
McRae MP; Lowe CM; Tian X; Bourdet DL; Ho RH; Leake BF; Kim RB; Brouwer KL; Kashuba AD
J Pharmacol Exp Ther; 2006 Sep; 318(3):1068-75. PubMed ID: 16720753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
